drugset / Trial / NCT06335888
A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis
Phase 2
Recruiting
70 enrolled
Insel Gruppe AG, University Hospital Bern
Paul Scherrer Institut, Center for Proton Therapy · collab
RandomizedCrossoverOpen-labelDiagnostic
Summary
The goal of this open-label clinical trial is to evaluate the efficacy of AzaFol-PET/CT in the diagnosis of GCA (giant cell arteritis), to compare AzaFol- with 2-\[18F\]FDG-PET/CT, and to assess the safety and tolerability of AzaFol in subjects with suspicion of GCA. Participants will undergo AzaFol-PET/CT imaging at a single timepoint.
Timeline
- Start
- 2025-02-03
- Primary completion
- 2029-05
- Completion
- 2029-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AzaFol | Diagnostic / imaging agent | — | — |
| Subject | FDG | Diagnostic / imaging agent | — | — |